Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
NiQuitin Clear 21mg patches
0410020B0BDADAR
|
NiQuitin | Nicotine | Central Nervous System | 3,067 |
|
NiQuitin 21mg patches
0410020B0BDAAAR
|
NiQuitin | Nicotine | Central Nervous System | 1,848 |
|
NiQuitin 14mg patches
0410020B0BDABAQ
|
NiQuitin | Nicotine | Central Nervous System | 1,235 |
|
NiQuitin Clear 14mg patches
0410020B0BDAEAQ
|
NiQuitin | Nicotine | Central Nervous System | 1,213 |
|
NiQuitin 7mg patches
0410020B0BDACAP
|
NiQuitin | Nicotine | Central Nervous System | 546 |
|
NiQuitin Minis Mint 4mg lozenges
0410020B0BDANAZ
|
NiQuitin | Nicotine | Central Nervous System | 543 |
|
NiQuitin Clear 7mg patches
0410020B0BDAFAP
|
NiQuitin | Nicotine | Central Nervous System | 493 |
|
NiQuitin Minis Mint 1.5mg lozenges
0410020B0BDAPBP
|
NiQuitin | Nicotine | Central Nervous System | 360 |
|
NiQuitin Minis Mint 2mg lozenges
0410020B0BDAWAY
|
NiQuitin | Nicotine | Central Nervous System | 275 |
|
NiQuitin Mint 2mg lozenges
0410020B0BDAKAY
|
NiQuitin | Nicotine | Central Nervous System | 154 |
|
NiQuitin Mint 4mg lozenges
0410020B0BDALAZ
|
NiQuitin | Nicotine | Central Nervous System | 147 |
|
NiQuitin Pre-Quit Clear 21mg patches
0410020B0BDARAR
|
NiQuitin | Nicotine | Central Nervous System | 27 |
|
NiQuitin 4mg lozenges original menthol mint
0410020B0BDAHAZ
|
NiQuitin | Nicotine | Central Nervous System | 24 |
|
NiQuitin 2mg lozenges original menthol mint
0410020B0BDAGAY
|
NiQuitin | Nicotine | Central Nervous System | 11 |
|
NiQuitin Fresh Mint 2mg medicated chewing gum
0410020B0BDAIBA
|
NiQuitin | Nicotine | Central Nervous System | 5 |
|
NiQuitin Minis Cherry 1.5mg lozenges
0410020B0BDAQBP
|
NiQuitin | Nicotine | Central Nervous System | 3 |
|
NiQuitin Extra Fresh Mint 2mg medicated chewing gum
0410020B0BDAUBA
|
NiQuitin | Nicotine | Central Nervous System | 1 |
|
NiQuitin Fresh Mint 4mg medicated chewing gum
0410020B0BDAJBD
|
NiQuitin | Nicotine | Central Nervous System | 1 |
|
NiQuitin Extra Fresh Mint 4mg medicated chewing gum
0410020B0BDAVBD
|
NiQuitin | Nicotine | Central Nervous System | No data available |
|
NiQuitin Minis Citrus 2mg lozenges
0410020B0BDAXAY
|
NiQuitin | Nicotine | Central Nervous System | No data available |
|
NiQuitin Minis Citrus 4mg lozenges
0410020B0BDAYAZ
|
NiQuitin | Nicotine | Central Nervous System | No data available |
|
NiQuitin Minis Orange 1.5mg lozenges
0410020B0BDATBP
|
NiQuitin | Nicotine | Central Nervous System | No data available |
|
NiQuitin Pre-Quit Mint 4mg lozenges
0410020B0BDAMAZ
|
NiQuitin | Nicotine | Central Nervous System | No data available |
|
NiQuitin Strips Mint 2.5mg oral films
0410020B0BDASCA
|
NiQuitin | Nicotine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.